Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel CDK2/cyclin A inhibitor effective antitumor agent in vivo

May 26, 2004

Enrollment under way in phase I study of NQO2 anticancer therapy

May 26, 2004

inGenium aids Peregrine's development of monoclonal antibody for lymphoma

May 25, 2004

Onco TCS NDA accepted for review

May 25, 2004

FDA approves Taxotere for treatment of prostate cancer

May 25, 2004

Two series of tyrosine kinase inhibitors described by BMS researchers

May 24, 2004

New CDK inhibitors for cancer and other disorders under study at Sanofi-Synthelabo

May 24, 2004

FDA approves Vidaza for treatment of MDS

May 24, 2004

3-Dimensional Pharmaceuticals claims new tyrosine kinase inhibitors and their use

May 21, 2004

Phase II trial of clofarabine in adult acute leukemia exceeds expectations

May 21, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...